| Course # | Course Name | Fall A | B |
Spring A | B |
Summer A | B |
Prerequisites & Notes |
|---|---|---|---|---|---|
| PHA 5270 | Health Care & Patient Safety | B | Offered in Spring A. Course being discontinued after Spring 2023. | ||
| PHA 5271 | Health Care Risk Management | B | Course being discontinued after Fall 2022. | ||
| PHA 6269 | Pharmaceutical Products & Public Policy | B | |||
| PHA 6273/6935* | Structure, Process & Outcomes of Regulation | A | |||
| PHA 6274 | Federal Regulation of Drugs & Pharmacy | B | It is strongly recommended that students take PHA (6273/6935) Structure, Process & Outcomes of Regulation prior to taking this course. | ||
| PHA 6275 | Federal Regulation of Controlled Substances | B | |||
| PHA 6276 | Pharmacy Benefit Design & Management | B | |||
| PHA 6277 | Ethics in Drug Production, Distribution & Use | A | |||
| PHA 6278 | State Regulation of Drugs & Pharmacy | A | 1. Offered every other year, in even-numbered years (e.g., 2020, 2022). 2. It is recommended that students take PHA (6273/6935) Structure, Process & Outcomes of Regulation prior to taking this course. |
||
| PHA 6279 | Pharmaceutical Outcomes & Policy Seminar | A/B Break | Course includes both Web-based and in-person assignments. In-person attendance is required for two-day (Sat-Sun) event, held on campus in Gainesville, FL. | ||
| PHA 6280 | Medicare & Medicaid | A | |||
| PHA 6283 | Commercial Applications / Pharmacoecon. Principles | B | B | ||
| PHA 6286 | Pharmaceutical Microeconomics | A | |||
| PHA 6287 | Pharmaceutical Health Economics | B | |||
| PHA 6793 | Evidentiary Basis of Pharmaceutical Use | B |
We are adding a second offering of this course. So it is now offered Fall B and Summer B. |
||
| PHA 6799 | Medication Safety and Quality Program Evaluation | A | Note that this course was previously offered in Summer B terms, but is now permanently scheduled for Summer A. | ||
| PHA 6806 | Pharmacoeconomic Modeling | A/B* | Prereqs: 1)Satisfactory completion of PHA 6283 Commercial Applications of Pharmacoeconomic Principles, and, 2) Satisfactory completion of PHA 6935 Quantitative Methods for Evidence-Based Pharmacy OR firm understanding of basic statistics. *Offered twice, in both Summer A and Summer B. Enrollment in the course may be capped. Students are advised to register for their selected term (A or B) as early as possible. |
||
| PHA 6891 | Introduction to Pharmacoepidemiology | A | |||
| PHA 6213 | Advanced Case Studies in Managed Care Pharmacy | B | Prereq: Satisfactory completion of PHA 6276 Pharmacy Benefit Design & Management OR permission of the instructor. | ||
| PHA 6211 | Managed Care Pharmacy Operations | A | Prereq: Satisfactory completion of PHA 6276 Pharmacy Benefit Design & Management OR permission of the instructor. | ||
| PHA 6246 | Medication Safety and Technology | B | Offered Spring B. Course likely being moved from Fall to Spring, and then then will be discontinued after 2023 | ||
| PHA 6935* | Pharm Data Analysis I: Data Management | B | Prereqs: 1)Satisfactory completion of PHA 6283 Commercial Applications of Pharmacoeconomic Principles, and, 2) Satisfactory completion of PHA 6935 Quantitative Methods for Evidence-Based Pharmacy OR firm understanding of basic statistics. |
||
| PHA 6935* | Pharm Data Analysis II: Risk Adjustment | A | Students must complete PHA 6935 Pharm. Data Analysis I: Data Management prior to taking this course. | ||
| PHA 6186 | POP Foundations I: Drug Discovery to Approval | A | The POP Foundation series includes two courses, POP Foundations I and POP Foundations II. Each course is independent, and students are not required to take POP Foundations I prior to taking POP Foundations II. | ||
| PHA 6187 | POP Foundations II: Marketing & Use | A | The POP Foundation series includes two courses, POP Foundations I and POP Foundations II. Each course is independent, and students are not required to take POP Foundations I prior to taking POP Foundations II. | ||
| PHA 6935* | Medication Error Prevention |
B | Course being discontinued after Summer 2023. | ||
| PHA 6795 | Quantitative Methods in Evidence-Based Pharmacy | A |
We are adding a second offering of this course. So it is now offered in Spring A and Summer A. |
||
| PHA 6935* | Writing for Pharmacy Outcomes & Policy (POP) | A | B | Summer C | 1. M.S. Students must successfully complete this course prior to taking their comprehensive final exam. 2. The Fall and Spring versions of this course are offered over a half-semester (7-8 weeks) and may require students to complete writing assignments on a short turnaround during the work week. The Summer version of this course is stretched over the entire Summer C semester (Summer A + B, or 12-13 weeks). Students in the Summer course generally have more lead-time to complete assignments, and may not need to work on assignments during the work week. |
| PHA 6791 | Systematic Review & Meta-Analysis for Pharmaceutical Interventions | B | Prior to taking this course, students must complete PHA 6793 Evidentiary Basis of Pharmaceutical Use (or its equivalent), and must have had prior graduate-level statistics coursework or undergraduate-level applied statistics. Students without prior statistics courses may be required to take PHA 6935 Quantitative Methods in Evidence-Based Pharmacy. | ||
| PHA 6797 | Applied Pharmaceutical Research Communications | A | |||
| MMC 5435 | Messaging Strategy and the Value Proposition | UF Fall semester: A/B | This is a full semester course, based on the standard UF academic calendar for the Fall semester. Course start and end dates may differ from other program courses. | ||
| MMC 6456 | Data Storytelling and Visualization | UF Fall semester: A/B | This is a full semester course, based on the standard UF academic calendar for the Fall semester. Course start and end dates may differ from other program courses. |
*PHA 6935 is used for courses that have not yet been assigned a permanent number in the Statewide Course Numbering System.
NOTE: Course offerings are subject to enrollment minimums and may be changed at any time.